These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10517116)
21. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725 [TBL] [Abstract][Full Text] [Related]
22. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related]
23. [Anomaly of polymerization of fibrin in a case of gamma-A myeloma]. Krick JA; Ménaché D Nouv Rev Fr Hematol; 1966; 6(5):744-8. PubMed ID: 4165868 [No Abstract] [Full Text] [Related]
24. A study of impaired fibrin polymerization in patients with the nephrotic syndrome. Mysliwiec M; Ralston A; Ackrill P; Poller L Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):73-8. PubMed ID: 1695187 [TBL] [Abstract][Full Text] [Related]
25. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum. Schorer AE; Singh J; Basara ML Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081 [TBL] [Abstract][Full Text] [Related]
26. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A. Crum ED; Shainoff JR; Graham RC; Ratnoff OD J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883 [TBL] [Abstract][Full Text] [Related]
28. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation. Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952 [TBL] [Abstract][Full Text] [Related]
29. Analysis of a fibrin formation abnormality in a case of multiple myeloma. Soria J; Soria C; Samama M; Fine JM; Bousser J Scand J Haematol; 1975 Oct; 15(3):207-18. PubMed ID: 812173 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function. Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594 [TBL] [Abstract][Full Text] [Related]
31. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma. Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991 [TBL] [Abstract][Full Text] [Related]
32. Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro. Lau A; Berry LR; Mitchell LG; Chan AK Thromb Res; 2007; 119(6):667-77. PubMed ID: 16793122 [TBL] [Abstract][Full Text] [Related]
33. A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. DiMinno G; Coraggio F; Cerbone AM; Capitanio AM; Manzo C; Spina M; Scarpato P; Dattoli GM; Mattioli PL; Mancini M J Clin Invest; 1986 Jan; 77(1):157-64. PubMed ID: 2935559 [TBL] [Abstract][Full Text] [Related]
35. Determination of Fibrinogen and Thrombin Time (TT). Undas A Methods Mol Biol; 2017; 1646():105-110. PubMed ID: 28804822 [TBL] [Abstract][Full Text] [Related]
36. Impaired ristocetin aggregation in myeloma due to binding of the aggregating agent by monoclonal protein--presentation of a case. László E; Péterfy M; Puskás E Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(6):852-6. PubMed ID: 2453415 [TBL] [Abstract][Full Text] [Related]
37. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
38. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681 [TBL] [Abstract][Full Text] [Related]